Harvey Pass

11PUBLICATIONS
142CO-AUTHORS
Predictive and prognostic markersTumour immunologyHaematological tumoursMedical infection agents (incl. prions)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 03, 2026
Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer.

|Apr 20, 2026
LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer.

|Sep 03, 2024
Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma.

Jun-Chieh J Tsay, Fares Darawshy, Chan Wang

|Jul 11, 2024
Germline <i>BARD1</i> variants predispose to mesothelioma by impairing DNA repair and calcium signaling.

Flavia Novelli, Yoshie Yoshikawa, Veronica Angela Maria Vitto

|Sep 20, 2023
HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma.

Joelle S Suarez, Flavia Novelli, Keisuke Goto

|Jul 28, 2023
Tumor-intrinsic LKB1-LIF signaling axis establishes a myeloid niche to promote immune evasion and tumor growth.

Ali Rashidfarrokhi, Ray Pillai, Yuan Hao

Pageof 2

Frequent Collaborators

5 joint publications

Haining Yang

4 joint publications

Joelle Suarez

4 joint publications

Flavia Novelli

4 joint publications

Ronghui Xu